""They're the most potent things that we've seen in health care since hormones," said Chris Shade, CEO of Quicksilver Scientific, a company that produces some oral versions of peptides."
""The FDA should ban these peptides from being imported, from being used, and force the companies that are making huge amounts of profit on them to do the proper studies," said Eric Topol, executive vice president of Scripps Research."
"Peptides already make up a $60 billion market and could top $180 billion in five years if the federal rules are relaxed, said Kate Festle, a managing director at West Monroe consultants."
""I think this has tremendous staying power because a lot of the companies that ... would be able to bundle this already exist. They have scale, they have membership," she said."
Self-administered peptide injections are increasingly popular among fitness enthusiasts and celebrities for their purported benefits in healing injuries, reducing inflammation, and anti-aging. Social media influencers have amplified interest, with figures like Joe Rogan discussing their use. The FDA is considering allowing compounding pharmacies to produce these peptides, which include BPC-157. While some experts praise their potential, others warn of health risks, including cancer, and call for stricter regulations. The peptide market is currently valued at $60 billion and could grow significantly if regulations are relaxed.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]